ENDS Report Issue 363, April 2005

Intelligence for environmental professionals. Britain's leading green business journal and website. Subscribe


  • DEFRA defends IPPC

    Faced with a deregulatory climate in Whitehall, DEFRA and the Environment Agency are arguing that IPPC is a spur to innovation

  • DTI on power-hungry TVs

    New TV screen technologies are threatening to drive up electricity demand - and the DTI is looking to voluntary action from the industry

  • Castle's dioxin dilemma

    Castle Cement's Padeswood works was the UK's biggest source of dioxins in 2004 - a finding which is forcing closure of three kilns

Waste management

  • Row on recycling exports

    The Environment Agency is on the spot over exports of household waste after Dutch regulators returned "contaminated" consignments


  • WWF on sustainable timber

    WWF has promised to bolster the credibility of its Forest Trade Network by publishing a report on its members' progress



  • Clean Neighbourhoods Act

    The Clean Neighbourhoods and Environment Bill has received Royal Assent after it was fast-tracked ahead of the general election


  • DEFRA seeks EUETS changes

    DEFRA has mooted a move away from "grandfathering" of emission rights in the next phase of the EU emissions trading scheme


UK policy

  • Chemical substitution plans

    The Government has set out its position on dealing with the highest risk chemicals under the proposed REACH chemicals regime

EU policy

  • U-turn on compostables

    The European Commission has abandoned plans for a Directive on biodegradable and compostable wastes


  • Election manifestos

    The two main political parties are reluctant to make the environment an issue in the election - but the manifestos offer some new policies

  • Water framework progress

    Implementing the water framework Directive is a challenging process - and raises concerns about who will pay for water pollution

  • GM debate rolls on

    Final results from the farm-scale evaluations of GM crops have dealt a blow to the biotechnology industry, and raise wider questions

Browse Print Editions